CMAJ • February 17, 2009; 180 (4). doi:10.1503/cmaj.081041.
© 2009 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Online Appendices
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, S. R.
Right arrow Articles by Bennett, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, S. R., BScPhm MSc
Right arrow Articles by Bennett, H., BPharm PhD
Related Collections
Right arrow Drugs: endocrine system
Right arrow Diabetes
Right arrowRelated Articles

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

Sumeet R. Singh, BScPhm MSc, Fida Ahmad, MSc, Avtar Lal, MD PhD, Changhua Yu, MD MSc, Zemin Bai, MD MSc and Heather Bennett, BPharm PhD

From the Canadian Agency for Drugs and Technologies in Health, Ottawa, Ont.


Figure 116
View larger version (21K):
[in this window]
[in a new window]

  		Figure 1: Selection of randomized controlled trials (RCTs) of rapid-acting insulin analogues for inclusion in the meta-analysis.

 

Figure 216
View larger version (19K):
[in this window]
[in a new window]

  		Figure 2: Selection of randomized controlled trials (RCTs) of long-acting insulin analogues for inclusion in the meta-analysis. *Thirty-four studies were included in the original health technology assessment;14 however, 4 abstracts143–146 were replaced by full-text publications identified during the update.

 

View this table:
[in this window]
[in a new window]

  		Table 1.

 

View this table:
[in this window]
[in a new window]

  		Table 2.

 

View this table:
[in this window]
[in a new window]

  		Table 3.

 

View this table:
[in this window]
[in a new window]

  		Table 4.